- Home
- XBIT vs TSVT Comparison
XBIT vs TSVT Comparison
Compare XBIT & TSVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- TSVT
- Stock Information
- Founded
- XBIT 2005
- TSVT 2021
- Country
- XBIT United States
- TSVT United States
- Employees
- XBIT N/A
- TSVT N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- TSVT Biotechnology: Pharmaceutical Preparations
- Sector
- XBIT Health Care
- TSVT Health Care
- Exchange
- XBIT Nasdaq
- TSVT Nasdaq
- Market Cap
- XBIT 242.2M
- TSVT 253.9M
- IPO Year
- XBIT 2015
- TSVT N/A
- Fundamental
- Price
- XBIT $7.60
- TSVT $4.77
- Analyst Decision
- XBIT
- TSVT Buy
- Analyst Count
- XBIT 0
- TSVT 6
- Target Price
- XBIT N/A
- TSVT $10.40
- AVG Volume (30 Days)
- XBIT 51.1K
- TSVT 344.9K
- Earning Date
- XBIT 11-07-2024
- TSVT 11-12-2024
- Dividend Yield
- XBIT N/A
- TSVT N/A
- EPS Growth
- XBIT N/A
- TSVT N/A
- EPS
- XBIT N/A
- TSVT N/A
- Revenue
- XBIT N/A
- TSVT $44,120,000.00
- Revenue This Year
- XBIT N/A
- TSVT N/A
- Revenue Next Year
- XBIT N/A
- TSVT $22.42
- P/E Ratio
- XBIT N/A
- TSVT N/A
- Revenue Growth
- XBIT N/A
- TSVT N/A
- 52 Week Low
- XBIT $3.51
- TSVT $1.54
- 52 Week High
- XBIT $9.96
- TSVT $6.40
- Technical
- Relative Strength Index (RSI)
- XBIT 57.48
- TSVT 52.14
- Support Level
- XBIT $7.05
- TSVT $4.44
- Resistance Level
- XBIT $7.93
- TSVT $4.92
- Average True Range (ATR)
- XBIT 0.58
- TSVT 0.33
- MACD
- XBIT 0.03
- TSVT -0.00
- Stochastic Oscillator
- XBIT 77.79
- TSVT 54.90
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.